Global Coronavirus Infection Market: Outline
Coronavirus is the type of virus that
belongs to either of the two subfamilies, Coronavirinae or Torovirinae
and it generally affects the respiratory tract of mammals. Coronavirus
is thus called as it has a crown-like appearance and in Latin, the word
‘corona’ means crown. Human coronaviruses (HCoV) were discovered in the
1960s from the naval cavities of patients affected with common cold.
These viruses cause a range of serious infections in humans from common
cold to severe respiratory problems. Coronavirus is spread through
droplets, i.e., by coughing or sneezing and there is a limited
possibility that this large family of virus can also be spread by close
contacts with an ability to pass from person to person. Sore throat,
coughing, fever, respiratory infection and difficulty in breathing are
some of the most common symptoms of coronavirus infection.
Global Coronavirus Infection Market: Key Categories
Based on the infections caused by coronavirus infection, the market can be segmented as follows:
- HCoV-229E: causes common cold, pneumonia, and bronchiolitis
- HCoV-OC43: causes respiratory tract infection and pneumonia in infants
- SARS-CoV: causes severe acute respiratory syndrome (SARS)
- New Haven CoV: causes Kawasaki disease, aneurysmsof the coronary arteries
- HKU1-CoV: causes acute respiratory distress and bilateral pneumonia
- MERS-CoV (Middle East respiratory syndrome coronavirus): causes bronchial infections
There are few coronavirus vaccines
available in the market such as inactivated coronavirus vaccine, live
attenuated coronavirus vaccine and S-Protein based coronavirus vaccine.
Various precautions and therapeutic drugs can also be taken to prevent
or minimize the effect of this fatal infection. Some of the precautions
are as follows:
- Standard precaution: hand hygiene, eye protection, disinfection of equipments etc.
- Droplet precaution: Use of medical mask and restricted patient movement
- Airborne precaution: Use of PPE (personal protective equipment), gloves etc.
Global Coronavirus Infection Market: Trends and Opportunities
Major driving factors for the growth of
coronary infection market are increase in the rate of communicable
diseases, disposable income in emerging countries, increasing number of
hospitals, and rising health hygiene of individuals across geographies.
Technological advancement and innovation about respiratory infection
treatment has also triggered the growth of the coronary infection
market. On the other hand, huge amount of capital involved in the market
would most likely impede the growth of this market.
Global Coronavirus Infection Market: Regional Outlook
Geographically, North America holds a
leading position in the coronary infection market followed by Europe.
The prime driving factors for the growth of this market in these regions
are increasing awareness among people regarding infectious viruses such
as SARS-CoV, shift to sophisticated treatment tools, and constantly
increasing segment of the population who acquire coronavirus infection.
According to the World Health Organization (WHO), around 1.1 million
people in the United States were hospitalized with pneumonia and 50,000
people died from this disease. Asia-Pacific is one of the fastest
growing regions and is the most lucrative market as this region is
expected to show a rapid growth in the near future. Major factors that
will boost the growth of the coronavirus infection market in
Asia-Pacific are high population density in countries like China and
India where there is high prevalence of contagious diseases, improved
healthcare infrastructure, and demand for novel drug therapeutics
related to coronavirus infected diseases.
Global Coronavirus Infection Market: Companies Covered under the Report
Some of the top major players operating
in the coronavirus market are Inovio Pharmaceuticals, Inc., Novavax,
Inc., Protein Potential, LLC, AlphaVax, Inc., Synairgen plc,
NanoViricides, Inc., GGeneCure, LLC and many others.
No comments:
Post a Comment